Baqsimi

Active Ingredient(s): Glucagon
FDA Approved: * July 24, 2019
Pharm Company: * ELI LILLY AND CO
Category: Hypoglycemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Baqsimi Overview

1BH0, 1NAU, 2G49, 2M5P, 2M5Q,%%s4ZGM, 4APD, 3IOL, 1D0R,%%s2L64, 2L63IdentifiersAliasesGCG, GLP1, glucagon, GRPP, GLP-1, GLP2External IDsOMIM: 138030 HomoloGene: 136497 GeneCards: GCG Gene location (Human)Chr.Chromosome 2 (human)[1]Band2q24.2Start162,142,882 bp[1]End162,152,404 bp[1]RNA expression patternMore reference expression dataGene ontologyMolecular function• GO:0001948 protein binding• identical protein binding• hormone ...

Read more Baqsimi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glucagon

Recent Baqsimi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glucagon
  • Injection: 0.5mg, 10mg/vial, 1mg, 1mg/vial
  • Powder: 1mg/vial, 3mg
  • Solution: 0.5mg/0.1ml (0.5mg/0.1ml), 1mg/0.2ml (1mg/0.2ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Baqsimi: (1 result)

Sorted by National Drug Code
  • 0002-6145 Baqsimi 3 mg Nasal Powder by Eli Lilly and Company

Other drugs which contain Glucagon or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 27 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA